Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. - Wikidata - awgldk - TriplyDB

Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.

Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.

http://www.wikidata.org/entity/Q35249476

about

Optical coherence tomography: from research to practice A chemical stability study of trimethylsilane plasma nanocoatings for coronary stents Optical Coherence Tomography: Potential Clinical Applications.Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis.Vascular response to bioresorbable polymer sirolimus-eluting stent vs. permanent polymer everolimus-eluting stent at 9-month follow-up: an optical coherence tomography sub-study from the CENTURY II trial Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.Coronary stent thrombosis: current insights into new drug-eluting stent designs Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry.A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease.The role of optical coherence tomography in coronary intervention New-generation drug-eluting stents: focus on Xience V® everolimus-eluting stent and Resolute® zotarolimus-eluting stent.Optical coherence tomography for evaluation of coronary stents in vivo.Stent evaluation with optical coherence tomography.Drug-eluting stents to prevent stent thrombosis and restenosis.Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.Optical Coherence Tomography Imaging: Novel Insights into the Vascular Response After Coronary Stent Implantation Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography.Serial three-dimensional optical coherence tomography assessment of strut coverage and intraluminal structures after drug-eluting stent implantation.Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up.Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison.Side branch healing patterns of the Tryton dedicated bifurcation stent: a 1-year optical coherence tomography follow-up study.Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.Improving vessel healing with fully bioresorbable drug-eluting stents: more than a pipe dream?Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy.Comparison of vascular response between everolimus-eluting stent and bare metal stent implantation in ST-segment elevation myocardial infarction assessed by optical coherence tomography.Rationale and study design of the RESERVOIR trial: a randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus.Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography study.Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis.Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.

P2860

Q26991471-72056D24-7EED-48D0-A9FE-8F27296B1EB0 Q28820958-FDF87CCC-0780-4152-9400-49E539186BA3 Q30465775-E763304E-1B1F-40FC-91E3-38CB94802676 Q35843028-01AAD37E-50FA-4D20-88C4-6541563CB2B4 Q36384518-136423BB-0855-43EE-9AAC-FCC351705272 Q36460858-F2635EF7-B07A-4AFA-8AAF-2A6EC8995FA9 Q36514842-E5387E87-636E-424E-AAB6-76A7413B6B93 Q36602870-5AFE7E4C-F2B1-4BCD-BB98-98B418929000 Q36954581-29656875-48DA-4BDA-8314-D6A7373FED20 Q37992043-AE1093D5-FA68-4218-A286-63E202F3FD7A Q38100805-D5C0964C-1657-4C78-BD73-6C6757D60191 Q38101964-2F6FE552-5A80-43F2-9019-0148A4BC4F57 Q38126880-B6436C56-14FA-4EF1-9A7C-67D4769E0CA3 Q38633332-C0E0D5E2-B2A8-4FDF-BDD6-1E981E4B10BA Q38657816-9E6723A8-C423-4206-9515-7DB75DBA9E19 Q38840807-91C4FD79-6D6E-42A9-8096-EBBAF99FC405 Q40364494-3CE14E20-65BD-40E8-8B8F-2C42C2132F89 Q41513424-A8CD3527-E273-4CAD-A242-A270C68832E2 Q42154709-3038C518-58D9-4812-A123-CB4E8625D204 Q44672104-EBA9C390-5066-4C75-AA5D-6F1839F90463 Q45739825-9E405121-9BCB-45EC-A1C3-35EEF4AD1EC4 Q45770520-CA4DFFF8-C25A-474A-B8F1-649FD6D8912B Q46875943-FAD849AC-CF05-4317-B6F0-DA0810156934 Q47891626-7BF6B3B2-76D6-4923-98F9-6D48F8E47BBB Q48199206-36F145C5-BD03-4E52-BD1D-ED15602D7A75 Q50854200-B4007AED-D803-47D4-BF1F-7A788738116F Q51066254-3EE03D63-E44D-4CBA-8EB7-5DE4C24DB5E0 Q51132223-E1770D7D-ED2E-4A94-BB61-5541A14B3A1E Q51170857-5CCAF7BD-9DBE-40CA-AB76-966AD3AC1F2B Q51584349-40107032-B90C-4B9E-A868-3FA1FA1E15E8 Q51682621-DCA5A0EC-0D14-4021-9321-27C35BE70FEF Q51810073-7267A044-325D-4720-9E4F-5DBE6951AB21 Q53384489-8620F83B-4DE0-4D23-902C-8295287E48C6 Q53395463-6FCE8C9B-A71D-4A85-B3C9-DF829A617099 Q53399613-65C31D4A-AE17-40AB-988C-69AF59DE7E53 Q53554369-6D69BE1F-AE89-4812-9721-12742348AE8B Q53626190-D72DA975-246B-451D-906B-55945145602F

P2860

Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.

http://www.wikidata.org/entity/Q35249476

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Tissue coverage of a hydrophil ...... the RESOLUTE All Comers trial.

@ast

Tissue coverage of a hydrophil ...... the RESOLUTE All Comers trial.

@en

type

label

Tissue coverage of a hydrophil ...... the RESOLUTE All Comers trial.

@ast

Tissue coverage of a hydrophil ...... the RESOLUTE All Comers trial.

@en

prefLabel

Tissue coverage of a hydrophil ...... the RESOLUTE All Comers trial.

@ast

Tissue coverage of a hydrophil ...... the RESOLUTE All Comers trial.

@en

P1433

Q35249476-49BA7CD0-1570-4E85-AF69-667EDC3C0FF3

P1476

Q35249476-A82B79C8-0F04-4439-8AA4-AD2565CBA1C2

P2093

Q35249476-212BF451-F84E-49D0-91E6-FC3FF546E688

Q35249476-52D17CDE-6FAB-40FE-9F08-513E361C7456

Q35249476-545B43BA-0A61-4793-8AD6-886B13DBB5F7

Q35249476-5FF3E626-1BA5-4AD1-AC95-2ABD5AD70AA5

Q35249476-629BC13B-50C7-4A04-B391-49DB6D409E3E

Q35249476-65614023-4922-4973-9B00-7303751AD8B5

Q35249476-8EA9F6CF-1874-43FE-B71C-3BCCB411B471

Q35249476-AC6C1A23-FD58-42E7-9441-021883C0AA07

Q35249476-C05AFDBE-7894-4F5D-A9D6-CD832CC4112D

Q35249476-D1762C20-796A-4E27-A284-064077EF03EA

P2860

Q35249476-0275D397-0EE5-4539-8A4E-14FAAE95FC3A

Q35249476-1DA9AC4C-2572-400F-A8AD-66D00B7D74BC

Q35249476-2B73A141-C3F4-43C7-B0B1-E7CC6E955B68

Q35249476-2CC21BEB-1E4D-4A27-9D39-0DE8DD2E9E9C

Q35249476-32CB35C1-3852-413E-92CC-D9AABAA219BF

Q35249476-3F00B596-344B-4549-A4A5-E8A142FBA04D

Q35249476-47088A1E-3F0E-4F30-9E00-F5999B28330E

Q35249476-480CDFD9-21BD-4B23-A078-83B3F6AFED9D

Q35249476-51AE62FF-6E19-418D-A85A-E176CA39F8C3

Q35249476-5A5E37D3-B338-4D76-9355-A2994181AD6C

P304

Q35249476-1F2C6561-A9B3-4997-894C-0177D4B442BD

P31

Q35249476-E90FF316-D214-40CC-9C3D-8C713DA1724D

P356

Q35249476-763BCE46-09E5-4A24-ADA7-D081E9B309C9

P433

Q35249476-F990D0D8-5571-4E81-96CF-E982F469D08A

P478

Q35249476-A359218D-FD27-4AC6-891C-0E213FB8095A

P50

Q35249476-78E7778E-DC25-4687-A4BB-DA7B4941BFA4

Q35249476-994D0678-170A-4543-87DF-441B62AFF5F6

Q35249476-FF4A65B6-1C75-4E53-8B02-65959E9F884F

P577

Q35249476-71D28219-CE87-46D9-B5F8-EDE0927B2A54

P5875

Q35249476-FDA8D020-2021-4330-B851-B4287E387050

P698

Q35249476-C9092A6F-A233-4E58-88F4-14B792BF26F4

P932

Q35249476-752D29AF-7213-42CA-93D2-CAA436B28FB2

P356

P1433

European Heart Journal

P1476

Tissue coverage of a hydrophil ...... the RESOLUTE All Comers trial.

@en

P2093

Carlo di Mario

http://www.w3.org/2001/XMLSchema#string

Evelyn Regar

http://www.w3.org/2001/XMLSchema#string

Francesco Borgia

http://www.w3.org/2001/XMLSchema#string

Henning Kelbæk

http://www.w3.org/2001/XMLSchema#string

Héctor M García-García

http://www.w3.org/2001/XMLSchema#string

Javier Escaned

http://www.w3.org/2001/XMLSchema#string

Juan Luis Gutiérrez-Chico

http://www.w3.org/2001/XMLSchema#string

Kari Saunamäki

http://www.w3.org/2001/XMLSchema#string

Nieves Gonzalo

http://www.w3.org/2001/XMLSchema#string

Robert Jan van Geuns

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis

Second-generation optical coherence tomography in clinical practice. High-speed data acquisition is highly reproducible in patients undergoing percutaneous coronary intervention.

Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy.

Coronary stents: current status.

Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI).

Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocard

P304

2454-2463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHR182

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Eveline Nüesch

Patrick W Serruys

Stephan Windecker

P577

2011-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51206936

http://www.w3.org/2001/XMLSchema#string

P698

21659439

http://www.w3.org/2001/XMLSchema#string

P932

3184229

http://www.w3.org/2001/XMLSchema#string